DOT Exam Version B: Advanced Medical Examiner Certification
Examination (Complex Clinical Scenarios & Regulatory Mastery)
Target Audience: Seasoned Certified Medical Examiners, Healthcare Professionals seeking NRCME
recertification, Advanced Practice Providers
Difficulty Level: Advanced/Expert
Total Questions: 150 Multiple-Choice Questions
General Instructions:
This examination is designed for the Advanced / Expert level candidate. Questions require synthesis
of FMCSA regulations, clinical guidelines, and nuanced judgment.
The examination uses current 2026-2027 regulatory updates and guidelines .
Each question has one best answer. Select the most comprehensive and clinically sound option.
Rationales are provided to reinforce learning and clarify complex regulatory interpretations.
Pay close attention to specific details such as timeframes, measurement values, and qualifying
criteria .
Section 1: Regulatory Framework, History Taking & Substance Use
(Questions 1-15)
1. A driver being evaluated for recertification presents a Health History Questionnaire that is
incomplete. The driver states, "I don't remember all that stuff, just check what you think is normal."
According to FMCSA guidelines and 49 CFR Part 391, what is the examiner's MOST appropriate
course of action?
A) Complete the examination based on the available information and note the driver's lack of
cooperation in the comments.
B) Proceed with the examination but document that the driver refused to complete the history, which
may be grounds for disqualification.
C) Refuse to perform the examination until a fully and accurately completed Medical Examination
,Report Form (MCSA-5875) is provided.
D) Have the driver sign a release to obtain their records from their primary care physician immediately.
Answer: C
Rationale: The driver must provide a complete and accurate medical history. The examiner cannot
"assume" normal findings. The driver's refusal to complete the history prevents the examiner from
conducting a full evaluation and makes certification impossible . Proceeding without a proper history
is a violation of the examination protocol and could lead to an unsafe certification.
2. A driver is currently prescribed and taking methadone for treatment of opioid use disorder
(OUD). The driver provides a letter from a Substance Abuse Professional (SAP) stating they are in
compliance with treatment and are "stable." What is the appropriate certification decision?
A) Certify for 1 year, with a requirement for follow-up SAP reports.
B) Certify for 6 months, with a requirement for a negative drug test.
C) Disqualify the driver. Methadone is an absolute disqualifier for interstate commercial driving.
D) Certify for 2 years, contingent on the driver providing a negative urine drug screen.
Answer: C
Rationale: The use of methadone for OUD is a Schedule II controlled substance and is an absolute
disqualifier under 49 CFR 391.41(b)(12) . Even with SAP approval and stability, the use of this specific
medication for this indication is prohibited. Other medications for OUD, such as buprenorphine, are
evaluated on a case-by-case basis, but methadone remains a hard disqualifier .
3. A driver reports a history of a single unprovoked seizure seven years ago. The driver has been off
anti-epileptic medication for four years and has had no further episodes. According to FMCSA
guidance, what is the correct action?
A) Certify the driver for 2 years. The driver is seizure-free and off medication.
B) Disqualify the driver. FMCSA requires an 8-year waiting period with specific off-medication criteria.
C) Certify the driver for 1 year with an annual neurology clearance.
D) Disqualify the driver until they obtain a seizure exemption from the FMCSA.
Answer: B
Rationale: FMCSA regulations require a specific waiting period for a driver with a history of a single
unprovoked seizure. The current guideline mandates a minimum of 8 years total: 4 years seizure-free
while on anti-epileptic medication, followed by 4 years seizure-free off all anti-epileptic medication .
,This driver has only been off medication for 4 years and has not met the total 8-year requirement. A
seizure exemption would not apply here as the waiting period hasn't been satisfied.
4. A driver reveals during the history that they use marijuana daily, legally under a state medical
marijuana program, for chronic pain. The driver provides a valid state-issued medical cannabis card.
What is the most appropriate action by the Medical Examiner?
A) Disqualify the driver. Federally, marijuana is a Schedule I controlled substance, and its use is
disqualifying.
B) Certify the driver for 2 years, but note "state-approved medical marijuana use" on the certificate.
C) Certify the driver for 1 year, provided they do not use the substance within 24 hours of driving.
D) Disqualify the driver for 3 months and refer them to a pain specialist.
Answer: A
Rationale: Despite state legalization, the use of marijuana (cannabis) is prohibited for drivers of
interstate commercial vehicles as it is a federally controlled substance . A medical card or state law
does not supersede FMCSA regulations. The examiner must disqualify the driver. This is a common and
important point of distinction .
5. A driver is legally prescribed a Schedule II stimulant, such as Adderall, for ADHD. The driver is
stable on the medication and reports no side effects. What is the maximum certification period and
what is the primary clinical concern the examiner must address?
A) 2 years, with a focus on ensuring the driver has no history of substance abuse.
B) 1 year, with a focus on ensuring the medication does not cause hypertension or tachycardia.
C) 1 year, with a focus on evaluating for potential cardiac side effects, such as palpitations or
arrhythmias.
D) 2 years, with a requirement for an annual psychiatric evaluation.
Answer: B
Rationale: A driver stable on a prescribed stimulant for a documented condition like ADHD may be
certified for a maximum of 1 year . While substance abuse history is relevant, the primary clinical
concern is the potential cardiovascular side effects of stimulant medications (hypertension,
tachycardia, palpitations) which could impair safe operation of a commercial vehicle . The examiner
must document that blood pressure and heart rate are within acceptable limits and the driver is stable.
6. Which of the following correctly differentiates a Schedule II from a Schedule IV controlled
substance in the context of DOT regulations?
, A) Schedule II drugs are allowed with a valid prescription, while Schedule IV drugs are not.
B) Schedule II drugs are automatically disqualifying if used for OUD, while Schedule IV drugs may be
allowed with review.
C) Schedule II drugs are for "street drugs" only, while Schedule IV drugs are for prescription
medications.
D) Schedule IV drugs have a higher potential for abuse than Schedule II drugs.
Answer: B
Rationale: The distinction is crucial . Schedule II substances have a high potential for abuse and
include opioids, amphetamines, and methadone. Schedule IV substances have a lower potential for
abuse and include some benzodiazepines and other sedatives . In DOT regulations, the use of
methadone (Schedule II) for OUD is an absolute disqualifier. Schedule IV drugs, when legally
prescribed and used for a valid medical condition (e.g., clonazepam for anxiety), may be allowed, but
the examiner must carefully evaluate for side effects.
7. A driver presents for an annual recertification. They are on a stable dose of buprenorphine for
OUD. They provide a letter from their treating physician stating they are in compliance with
treatment, have had no relapses, and are stable. The driver has a history of multiple positive drug
tests in the past, but the most recent test was negative. What is the most appropriate decision?
A) Disqualify due to the history of OUD. Any history is an automatic disqualifier.
B) Disqualify due to the use of buprenorphine for OUD.
C) Certify for up to 1 year, with a requirement for a signed release of information to the SAP, and
documentation of treatment compliance and drug test results.
D) Certify for up to 3 months and require a negative drug test and a new SAP evaluation.
Answer: C
Rationale: Unlike methadone, buprenorphine is not an automatic disqualifier . A driver with a history
of OUD who is successfully treated and stable on a medication like buprenorphine, with documented
compliance and negative drug tests, may be certified for up to one year . The examiner must obtain a
release of information, require documentation of treatment compliance, and evaluate the driver for
any side effects of the medication that could impair driving.
8. A driver who is a heavy smoker reports chronic bronchitis with a productive cough. The driver's
physical exam reveals expiratory wheezing. The examiner obtains a pulmonary function test (PFT).
The Forced Expiratory Volume in one second (FEV1) is 55% of the predicted value. What is the
certification decision?
Examination (Complex Clinical Scenarios & Regulatory Mastery)
Target Audience: Seasoned Certified Medical Examiners, Healthcare Professionals seeking NRCME
recertification, Advanced Practice Providers
Difficulty Level: Advanced/Expert
Total Questions: 150 Multiple-Choice Questions
General Instructions:
This examination is designed for the Advanced / Expert level candidate. Questions require synthesis
of FMCSA regulations, clinical guidelines, and nuanced judgment.
The examination uses current 2026-2027 regulatory updates and guidelines .
Each question has one best answer. Select the most comprehensive and clinically sound option.
Rationales are provided to reinforce learning and clarify complex regulatory interpretations.
Pay close attention to specific details such as timeframes, measurement values, and qualifying
criteria .
Section 1: Regulatory Framework, History Taking & Substance Use
(Questions 1-15)
1. A driver being evaluated for recertification presents a Health History Questionnaire that is
incomplete. The driver states, "I don't remember all that stuff, just check what you think is normal."
According to FMCSA guidelines and 49 CFR Part 391, what is the examiner's MOST appropriate
course of action?
A) Complete the examination based on the available information and note the driver's lack of
cooperation in the comments.
B) Proceed with the examination but document that the driver refused to complete the history, which
may be grounds for disqualification.
C) Refuse to perform the examination until a fully and accurately completed Medical Examination
,Report Form (MCSA-5875) is provided.
D) Have the driver sign a release to obtain their records from their primary care physician immediately.
Answer: C
Rationale: The driver must provide a complete and accurate medical history. The examiner cannot
"assume" normal findings. The driver's refusal to complete the history prevents the examiner from
conducting a full evaluation and makes certification impossible . Proceeding without a proper history
is a violation of the examination protocol and could lead to an unsafe certification.
2. A driver is currently prescribed and taking methadone for treatment of opioid use disorder
(OUD). The driver provides a letter from a Substance Abuse Professional (SAP) stating they are in
compliance with treatment and are "stable." What is the appropriate certification decision?
A) Certify for 1 year, with a requirement for follow-up SAP reports.
B) Certify for 6 months, with a requirement for a negative drug test.
C) Disqualify the driver. Methadone is an absolute disqualifier for interstate commercial driving.
D) Certify for 2 years, contingent on the driver providing a negative urine drug screen.
Answer: C
Rationale: The use of methadone for OUD is a Schedule II controlled substance and is an absolute
disqualifier under 49 CFR 391.41(b)(12) . Even with SAP approval and stability, the use of this specific
medication for this indication is prohibited. Other medications for OUD, such as buprenorphine, are
evaluated on a case-by-case basis, but methadone remains a hard disqualifier .
3. A driver reports a history of a single unprovoked seizure seven years ago. The driver has been off
anti-epileptic medication for four years and has had no further episodes. According to FMCSA
guidance, what is the correct action?
A) Certify the driver for 2 years. The driver is seizure-free and off medication.
B) Disqualify the driver. FMCSA requires an 8-year waiting period with specific off-medication criteria.
C) Certify the driver for 1 year with an annual neurology clearance.
D) Disqualify the driver until they obtain a seizure exemption from the FMCSA.
Answer: B
Rationale: FMCSA regulations require a specific waiting period for a driver with a history of a single
unprovoked seizure. The current guideline mandates a minimum of 8 years total: 4 years seizure-free
while on anti-epileptic medication, followed by 4 years seizure-free off all anti-epileptic medication .
,This driver has only been off medication for 4 years and has not met the total 8-year requirement. A
seizure exemption would not apply here as the waiting period hasn't been satisfied.
4. A driver reveals during the history that they use marijuana daily, legally under a state medical
marijuana program, for chronic pain. The driver provides a valid state-issued medical cannabis card.
What is the most appropriate action by the Medical Examiner?
A) Disqualify the driver. Federally, marijuana is a Schedule I controlled substance, and its use is
disqualifying.
B) Certify the driver for 2 years, but note "state-approved medical marijuana use" on the certificate.
C) Certify the driver for 1 year, provided they do not use the substance within 24 hours of driving.
D) Disqualify the driver for 3 months and refer them to a pain specialist.
Answer: A
Rationale: Despite state legalization, the use of marijuana (cannabis) is prohibited for drivers of
interstate commercial vehicles as it is a federally controlled substance . A medical card or state law
does not supersede FMCSA regulations. The examiner must disqualify the driver. This is a common and
important point of distinction .
5. A driver is legally prescribed a Schedule II stimulant, such as Adderall, for ADHD. The driver is
stable on the medication and reports no side effects. What is the maximum certification period and
what is the primary clinical concern the examiner must address?
A) 2 years, with a focus on ensuring the driver has no history of substance abuse.
B) 1 year, with a focus on ensuring the medication does not cause hypertension or tachycardia.
C) 1 year, with a focus on evaluating for potential cardiac side effects, such as palpitations or
arrhythmias.
D) 2 years, with a requirement for an annual psychiatric evaluation.
Answer: B
Rationale: A driver stable on a prescribed stimulant for a documented condition like ADHD may be
certified for a maximum of 1 year . While substance abuse history is relevant, the primary clinical
concern is the potential cardiovascular side effects of stimulant medications (hypertension,
tachycardia, palpitations) which could impair safe operation of a commercial vehicle . The examiner
must document that blood pressure and heart rate are within acceptable limits and the driver is stable.
6. Which of the following correctly differentiates a Schedule II from a Schedule IV controlled
substance in the context of DOT regulations?
, A) Schedule II drugs are allowed with a valid prescription, while Schedule IV drugs are not.
B) Schedule II drugs are automatically disqualifying if used for OUD, while Schedule IV drugs may be
allowed with review.
C) Schedule II drugs are for "street drugs" only, while Schedule IV drugs are for prescription
medications.
D) Schedule IV drugs have a higher potential for abuse than Schedule II drugs.
Answer: B
Rationale: The distinction is crucial . Schedule II substances have a high potential for abuse and
include opioids, amphetamines, and methadone. Schedule IV substances have a lower potential for
abuse and include some benzodiazepines and other sedatives . In DOT regulations, the use of
methadone (Schedule II) for OUD is an absolute disqualifier. Schedule IV drugs, when legally
prescribed and used for a valid medical condition (e.g., clonazepam for anxiety), may be allowed, but
the examiner must carefully evaluate for side effects.
7. A driver presents for an annual recertification. They are on a stable dose of buprenorphine for
OUD. They provide a letter from their treating physician stating they are in compliance with
treatment, have had no relapses, and are stable. The driver has a history of multiple positive drug
tests in the past, but the most recent test was negative. What is the most appropriate decision?
A) Disqualify due to the history of OUD. Any history is an automatic disqualifier.
B) Disqualify due to the use of buprenorphine for OUD.
C) Certify for up to 1 year, with a requirement for a signed release of information to the SAP, and
documentation of treatment compliance and drug test results.
D) Certify for up to 3 months and require a negative drug test and a new SAP evaluation.
Answer: C
Rationale: Unlike methadone, buprenorphine is not an automatic disqualifier . A driver with a history
of OUD who is successfully treated and stable on a medication like buprenorphine, with documented
compliance and negative drug tests, may be certified for up to one year . The examiner must obtain a
release of information, require documentation of treatment compliance, and evaluate the driver for
any side effects of the medication that could impair driving.
8. A driver who is a heavy smoker reports chronic bronchitis with a productive cough. The driver's
physical exam reveals expiratory wheezing. The examiner obtains a pulmonary function test (PFT).
The Forced Expiratory Volume in one second (FEV1) is 55% of the predicted value. What is the
certification decision?
